Free Trial
OTCMKTS:ISCO

International Stem Cell (ISCO) Stock Price, News & Analysis

International Stem Cell logo
$0.13 +0.00 (+0.31%)
As of 11:01 AM Eastern

About International Stem Cell Stock (OTCMKTS:ISCO)

Key Stats

Today's Range
$0.13
$0.13
50-Day Range
$0.12
$0.20
52-Week Range
$0.05
$0.27
Volume
10,391 shs
Average Volume
6,320 shs
Market Capitalization
$1.05 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive ISCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for International Stem Cell and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

ISCO Stock News Headlines

BONUS GUIDE - Ben Stein Prepares For the Next Financial Crisis
With inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist Ben Stein—drawing on insights from his own experience and his father’s time advising two U.S. presidents—just released a new report on how to help protect your retirement from the next major crisis.tc pixel
See More Headlines

ISCO Stock Analysis - Frequently Asked Questions

International Stem Cell's stock was trading at $0.0813 at the start of the year. Since then, ISCO stock has increased by 61.7% and is now trading at $0.1315.

International Stem Cell Corp. (OTCMKTS:ISCO) released its quarterly earnings data on Thursday, August, 14th. The biotechnology company reported $0.01 earnings per share (EPS) for the quarter. The biotechnology company earned $2.45 million during the quarter.

Shares of ISCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that International Stem Cell investors own include Canopy Growth (CGC), Aurora Cannabis (ACB), Amarantus Bioscience (AMBS), Fulcrum Therapeutics (FULC), Kutcho Copper (KCCFF), B2Gold (BTG) and Cannabis Wheaton Income (CBWTF).

Company Calendar

Last Earnings
8/14/2025
Today
8/29/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
MED - BIOMED/GENE
Sub-Industry
Pharmaceutical Products
Current Symbol
OTCMKTS:ISCO
CIK
1355790
Employees
30
Year Founded
2001

Profitability

EPS (Trailing Twelve Months)
($0.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$210 thousand
Net Margins
-3.29%
Pretax Margin
-2.62%
Return on Equity
N/A
Return on Assets
-5.63%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.78
Quick Ratio
0.46

Sales & Book Value

Annual Sales
$9.09 million
Price / Sales
0.12
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($0.49) per share
Price / Book
-0.27

Miscellaneous

Outstanding Shares
8,004,000
Free Float
1,324,000
Market Cap
$1.05 million
Optionable
Not Optionable
Beta
-0.07

Social Links

10 Best Stocks to Own: Fall 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Fall 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (OTCMKTS:ISCO) was last updated on 8/29/2025 by MarketBeat.com Staff
From Our Partners